Excretion of a radioiodine in human milk following a therapeutic dose of I-131

Simple item page
dc.contributor.authorRubow S.
dc.contributor.authorKlopper J.
dc.date.accessioned2011-05-15T16:16:20Z
dc.date.available2011-05-15T16:16:20Z
dc.date.issued1988
dc.description.abstractAn investigation of 131I excretion into human milk after a therapeutic dose of 5142 MBq (139 mCi) 131I, in a patient who has had a thyroidectomy is presented. During the first 36 h, 17.4% of the administered dose was excreted into the milk. In addition to the known radiation risk, this may affect the quantity of 131I retained by the thyroid and metastases.
dc.description.versionArticle
dc.identifier.citationEuropean Journal of Nuclear Medicine
dc.identifier.citation14
dc.identifier.citation12
dc.identifier.issn03406997
dc.identifier.urihttp://hdl.handle.net/10019.1/13739
dc.subjectiodine 131
dc.subjectmilk
dc.subjectadult
dc.subjectcase report
dc.subjectfemale
dc.subjecthuman
dc.subjectlactation
dc.subjectoral drug administration
dc.subjectradioactive contamination
dc.subjectradioisotope therapy
dc.subjectthyroid carcinoma
dc.subjectAdult
dc.subjectBreast Feeding
dc.subjectCarcinoma, Papillary
dc.subjectCase Report
dc.subjectFemale
dc.subjectHuman
dc.subjectIodine Radioisotopes
dc.subjectMilk, Human
dc.subjectMonitoring, Physiologic
dc.subjectThyroid Neoplasms
dc.titleExcretion of a radioiodine in human milk following a therapeutic dose of I-131
dc.typeArticle
Files
Collections
Stellenbosch University - Scopus Tygerberg Hospital Publications